News 2014-09-12
2014 Semi-Annual & OD project summary conference
The conference of 2014 semi-annual and OD project summary was held on Aug. 31st to Sep. 2nd 2014 at Jin Fo Shan in Nanshuan District.
During the meeting, we summarized the progress of “Three Battles (BPM, GMP and KAM)”which were confirmed at the beginning of this year. We also concluded and analyzed the performance of each economic indicator in H1 of 2014.
The redefined core values and its connotations were officially published on Sep. 1st, 2014, and thus determined the concept of Porton culture on its mission, vision and core values.
Others
More
News 2026-08-05
Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization
Porton Advanced Solutions Ltd. has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA). This milestone qualifies Porton Advanced to undertake commercial contract manufacturing for Cell and Gene Therapy (CGT) products, extending its CDMO services from process development and clinical production through to the commercialization stage.
News 2026-07-08
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
